Co-Authors
This is a "connection" page, showing publications co-authored by Paul Verweij and Bart Rijnders.
Connection Strength
0.905
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.238
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.222
-
The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol. Mycoses. 2018 Sep; 61(9):656-664.
Score: 0.194
-
Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study. Med Mycol. 2020 Jun 01; 58(4):444-452.
Score: 0.055
-
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. J Antimicrob Chemother. 2019 09 01; 74(9):2759-2766.
Score: 0.053
-
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2018 12; 31(6):471-480.
Score: 0.050
-
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 10; 6(10):782-792.
Score: 0.049
-
Influenza-Associated Aspergillosis in Critically Ill Patients. Am J Respir Crit Care Med. 2017 08 15; 196(4):524-527.
Score: 0.044